BDBM718790 Preparation of (1S,3R)-3-(4-methyl-4H-1,2,4-triazol-3-yl)-3-(3-(8-methyl-6-(((S)-3-methylpiperidin-1-yl)methyl)-4-oxo-4H-chromen-3-yl)phenyl)cyclobutylacetonitrile ::US20250042896, Compound 68

SMILES Cc1cc(CN2CCC[C@H](C)C2)cc2c(=O)c(-c3cccc([C@]4(c5nncn5C)C[C@H](C#N)C4)c3)coc12

InChI Key InChIKey=HYHJGCSNUHOQMN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 718790   

TargetE3 ubiquitin-protein ligase CBL-B/(E3-independent) E2 ubiquitin-conjugating enzyme D2(Human)
Hainan Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM718790(Preparation of (1S,3R)-3-(4-methyl-4H-1,2,4-triazo...)
Affinity DataIC50: 17.8nMAssay Description:Experiment purpose: Testing of inhibitory activity of compounds on the interaction between Cbl-b protein and UbcH5B-Ub. Experimental method: Eu-Ubqui...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent